Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case report

RATIONALE: Mutations in epidermal growth factor receptor (EGFR) play critical roles in the pathogenesis of non–small cell lung cancer (NSCLC), and they are highly associated with sensitivity to tyrosine kinase inhibitors. Targeted therapies are approved for patients with “classical” mutations and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Bin, Wang, Yanan, Liao, Haijiang, Li, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388040/
https://www.ncbi.nlm.nih.gov/pubmed/35984165
http://dx.doi.org/10.1097/MD.0000000000030080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388040/
https://www.ncbi.nlm.nih.gov/pubmed/35984165
http://dx.doi.org/10.1097/MD.0000000000030080

Ejemplares similares